Contracts Finder · Award
Exact Sciences - Oncotype DX Breast Recurrence Score tests
A public procurement published by Norfolk and Norwich University Hospitals NHS Foundation Trust via Contracts Finder.
- £340.2k
- Award value
- £87.5k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Call off contract from framework.
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 85121200 — Medical specialist services
- Currency
- GBP
- Total award value
- £340,202
- Tender value
- £87,480
- First published
- 23 Apr 2024
- Last updated
- 23 Apr 2024
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Exact Sciences UK, Ltd. | 07484560 | 5 Mar 2024 | active | £340.2k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Norfolk and Norwich University Hospitals NHS Foundation Trust
FAQs about this procurement
Who is the buyer for "Exact Sciences - Oncotype DX Breast Recurrence Score tests"?
Exact Sciences - Oncotype DX Breast Recurrence Score tests is a UK public-sector procurement published by Norfolk and Norwich University Hospitals NHS Foundation Trust via Contracts Finder.
Has "Exact Sciences - Oncotype DX Breast Recurrence Score tests" been awarded?
Yes — 1 award is recorded, with a reported total value of £340,202. The current lifecycle stage is "Award".
Which suppliers are involved in "Exact Sciences - Oncotype DX Breast Recurrence Score tests"?
1 supplier is linked: Exact Sciences UK, Ltd..
What is "Exact Sciences - Oncotype DX Breast Recurrence Score tests" worth?
The reported award value is £340,202.
When was "Exact Sciences - Oncotype DX Breast Recurrence Score tests" published?
It was first published on 23 Apr 2024 and last updated on 23 Apr 2024, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable